Kidney Disease: Three Studies At-a-Glance
Highlighted: Chronic kidney disease and stroke risk, syphilis in ESRD patients, and how healthy diets may reduce CKD incidence.
Autosomal-dominant Polycystic Kidney Disease: 3 Studies in Brief
Three new studies on ADPKD treatment project long-term impact of tolvaptan; reveal potential in an existing drug class; and, report success in slowing comorbid hepatic disease.
For ADPKD in Children, New Guidelines Speak to Ethical Issues
Most children with ADPKD remain asymptomatic, but some manifest early and aggressive disease. Try our 6 questions on the new expert guidance on tricky treatment issues.
Polycystic Kidney Disease: What's Your ADPKD IQ?
Autosomal dominant polycystic kidney disease is the most common form of polycystic renal disease. Find out what you know about ADPKD with this 7-question quiz on epidemiology, diagnosis, and more.
Chronic Kidney Disease: 7 Questions for Primary Care
The primary care role in detection, management, and reducing the risk of progression of CKD continues to expand. Test yourself here on basics in each category.
Loop Diuretics During Dialysis Reduce Hospitalization, Hypotension, Weight Gain
Keeping a loop diuretic on board during dialysis could be an effective, low-cost option to help improve patient outcomes, according to a new study.
5 Qs on Managing Hepatitis C in the Young
How much do you know about HCV treatment in children and teens? Take this short, 5-question quiz to find out.
HCV in Young Adults and Children: 3 Studies At-a-Glance
Study summaries highlight increased infection rates in young adults; a spike in HCV in reproductive-aged women; and a potential new treatment for HCV in young children.
Hep C Quiz: 5 Questions on the News
ICYMI: HCV elimination success, SVR in blacks, transplant delisting, clearance after acute infection-catch up with a quiz.
Organ Transplant in the Direct-acting Antiviral Era
Can DAA therapy remove patients from transplant waiting lists? Are HCV-infected livers--and hearts--safe for uninfected organ recipients? Three new studies explain.
Hep C Expert Interview: Gregory T. Everson, MD
Renowned transplant expert Gregory T. Everson, MD, talked with Patient Care about sensitive issues surrounding liver transplant in the era of direct-acting antiviral therapy.
HCV Quiz: 5 Simple Questions, Very Interesting Answers
Sample: Which type of practitioner most often makes the diagnosis of HCV: Gastro? GP? Hepatologist? Other?
Interview with HCV Expert Paul Kwo, MD
Patient Care talked with Dr Kwo about recent updates to hepatitis C management guidelines, challenges in expanding screening, and more.
How to Improve HCV Screening Rates: A 6-Step QI Experience
HCV screening rates improved at one large clinic from 24% to over 90% and were sustained at 1 year. How? With this 6-step intervention.
Hep C Guidance Update Quiz: Special Populations
The newest HCV guidance is out on special populations. Are you up to date? Take our short, 5-question quiz to find out.
Where Direct Acting Agents Fail, a New Retreatment Strategy May Win
For patients infected with hepatitis C virus who do not respond to direct-acting antiviral agents, results of a new study could mean a much brighter future.
National HCV Elimination Programs Show Early Success in Treatment and Cure
Two new international studies on HCV show elimination programs have high levels of engagement, treatment initiation, and cure rates.
Hep C Quizlet: 5 Short Questions
These 5 questions on HCV infection are a quick brush-up on disease basics and treatment.
3 Key Questions in T2DM Care: CV Protection, Cost, and A1c Goals
Who gets the cardioprotective agents? Are newer agents affordable? And, how low should A1c go?
Small-town EDs May Have Large Impact on HCV Screening
HCV screening of baby boomers seen in a suburban emergency department found remarkably high seropositivity rates, say authors of a new study.
Elbasvir/grazoprevir Efficacy High in Black Adults with HCV Infection
The current study was one of the largest analyses to date of black participants receiving all-oral DAA treatment.
Cost of Care: 5 Tips on How to Talk to Patients
Talking to your patients about cost of care can be difficult, but these five strategies are sure to help.
Dementia and Agitation: A Case Challenge
How would you manage a patient with dementia and agitation? Take our 4-question case challenge from the 2018 ACP Internal Medicine Meeting to find out.
HCV Screening, Transmission, and Treatment: A Test
This new quiz on hepatitis C tests what you know about mother-to-child transmission, testing at-risk populations, optimal regimens for your sickest patients, and more.
Mastering Rheumatoid Arthritis: 5 Key Challenges for Primary Care Practice
RA can be managed in primary care but comes with unique challenges. Here, strategies outlined at the ACP Internal Medicine Meeting 2018.
Treatment-resistant Depression: 5 Steps to Follow for Primary Care
Five tips for PCPs on managing treatment-resistant depression were offered at the ACP Internal Medicine Meeting 2018 today. Patient Care offers a summary.
Glecaprevir-pibrentasvir in HCV Genotypes 1 & 3: SVR Rates High after 8 Weeks
The recently-approved HCV treatment produced SVR rates of 95% or greater and discontinuation rates for AEs were extremely low.
Baby Boomer HCV Screening Rates Remain Low, Study Finds
Black and Hispanic boomers had lower odds of HCV screening between 2013-2015, as did female and older members of the 1945-1965 cohort.
